Yesterday, we hosted James Duncan, Ph.D., Chair of Biomedical Engineering at Yale University, as a 2026 Distinguished Seminar. Dr. Duncan shared how advanced fMRI and AI methods enable objective biomarkers and more personalized treatment insights for autism spectrum disorders.